Paper36950503
The application of corticosteroids for pathological scar prevention and treatment: current review and update.
Sheng M and 4 others. Burns Trauma, 2023. Cited by 53 papers, by iCite.
Cite this record
ConductScience Library. The application of corticosteroids for pathological scar prevention and treatment: current review and update. Papers, record 36950503. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/36950503
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- The application of corticosteroids for pathological scar prevention and treatment: current review and update.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References80
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 24490743 | Lasers as an approach for promoting drug delivery via skin. | Expert Opin Drug Deliv | 2014 | https://conductscience.org/library/papers/24490743 | PubMed |
| 2 | 30151017 | Role of betamethasone valerate 2.250 mg medicated plaster in the treatment of psoriasis and other dermatological pathologies: a review. | Drugs Context | 2018 | https://conductscience.org/library/papers/30151017 | PubMed |
| 3 | 7679551 | Acidic and basic fibroblast growth factors down-regulate collagen gene expression in keloid fibroblasts. | Am J Pathol | 1993 | https://conductscience.org/library/papers/7679551 | PubMed |
| 4 | 34361084 | Lipid-Based Nanosystems as a Tool to Overcome Skin Barrier. | Int J Mol Sci | 2021 | https://conductscience.org/library/papers/34361084 | PubMed |
| 5 | 36169040 | Overcoming skin barriers through advanced transdermal drug delivery approaches. | J Control Release | 2022 | https://conductscience.org/library/papers/36169040 | PubMed |
| 6 | 22954589 | Mechanisms of the anti-inflammatory effects of glucocorticoids: genomic and nongenomic interference with MAPK signaling pathways. | FASEB J | 2012 | https://conductscience.org/library/papers/22954589 | PubMed |
| 7 | 33719380 | Topical Corticosteroids: Choice and Application. | Am Fam Physician | 2021 | https://conductscience.org/library/papers/33719380 | PubMed |
| 8 | 34785356 | Trilayer microneedle array assisted transdermal and intradermal delivery of dexamethasone. | Int J Pharm | 2022 | https://conductscience.org/library/papers/34785356 | PubMed |
| 9 | 22272655 | A new uniform protocol of combined corticosteroid injections and ointment application reduces recurrence rates after surgical keloid/hypertrophic scar excision. | Dermatol Surg | 2012 | https://conductscience.org/library/papers/22272655 | PubMed |
| 10 | 12920152 | The interplay between the glucocorticoid receptor and nuclear factor-kappaB or activator protein-1: molecular mechanisms for gene repression. | Endocr Rev | 2003 | https://conductscience.org/library/papers/12920152 | PubMed |
| 11 | 3470308 | Transforming growth factor-beta increases steady state levels of type I procollagen and fibronectin messenger RNAs posttranscriptionally in cultured human dermal fibroblasts. | J Clin Invest | 1987 | https://conductscience.org/library/papers/3470308 | PubMed |
| 12 | 25068544 | Updated international clinical recommendations on scar management: part 2--algorithms for scar prevention and treatment. | Dermatol Surg | 2014 | https://conductscience.org/library/papers/25068544 | PubMed |
| 13 | 18997767 | Transdermal drug delivery. | Nat Biotechnol | 2008 | https://conductscience.org/library/papers/18997767 | PubMed |
| 14 | 32910934 | Insights into glucocorticoid responses derived from omics studies. | Pharmacol Ther | 2021 | https://conductscience.org/library/papers/32910934 | PubMed |
| 15 | 10513931 | On the nature of hypertrophic scars and keloids: a review. | Plast Reconstr Surg | 1999 | https://conductscience.org/library/papers/10513931 | PubMed |
| 16 | 25006550 | Development and evaluation of solid lipid nanoparticles of mometasone furoate for topical delivery. | Int J Pharm Investig | 2014 | https://conductscience.org/library/papers/25006550 | PubMed |
| 17 | 11386039 | Topical steroids--a new approach after 50 years. | Med Sci Monit | 2001 | https://conductscience.org/library/papers/11386039 | PubMed |
| 18 | 11817968 | New and established topical corticosteroids in dermatology: clinical pharmacology and therapeutic use. | Am J Clin Dermatol | 2002 | https://conductscience.org/library/papers/11817968 | PubMed |
| 19 | 12174062 | Triamcinolone stimulates bFGF production and inhibits TGF-beta1 production by human dermal fibroblasts. | Dermatol Surg | 2002 | https://conductscience.org/library/papers/12174062 | PubMed |
| 20 | 21735339 | Clinical characteristics of facial keloids treated with surgical excision followed by intra- and postoperative intralesional steroid injections. | Aesthetic Plast Surg | 2012 | https://conductscience.org/library/papers/21735339 | PubMed |
Cited by35
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 53 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42973896 | Management of Axillary Burn Sequelae: Prevention, Surgical Treatment and Functional Outcomes. | Ann Burns Fire Disasters | 2026 | https://conductscience.org/library/papers/42973896 | PubMed |
| 42825928 | Treatment of hypertrophic scars using fractional CO2 laser alone in comparison with adding botulinium toxin either intalesional injection or assisted drug delivery. | Lasers Med Sci | 2026 | https://conductscience.org/library/papers/42825928 | PubMed |
| 42780693 | Current therapeutic strategies and available research models for investigating hypertrophic scars. | Front Pharmacol | 2026 | https://conductscience.org/library/papers/42780693 | PubMed |
| 42657113 | Hydrogel microneedles functioning in pathological surroundings: where soft materials overcome hard scars. | Mater Today Bio | 2026 | https://conductscience.org/library/papers/42657113 | PubMed |
| 42621324 | Targeting macrophage function with botulinum toxin: a novel translational strategy for preventing and treating pathological scars. | Postepy Dermatol Alergol | 2026 | https://conductscience.org/library/papers/42621324 | PubMed |
| 42461415 | Combined compound betamethasone and 595 nm pulsed dye laser improves hypertrophic scar and is associated with enhanced autophagy in myofibroblasts. | Lasers Med Sci | 2026 | https://conductscience.org/library/papers/42461415 | PubMed |
| 42321277 | A combinatorial therapeutic platform based on graphene-collagen cryogel and apoptotic vesicles for modulating hypertrophic scars. | Sci Rep | 2026 | https://conductscience.org/library/papers/42321277 | PubMed |
| 42260901 | Resveratrol Ameliorates Hypertrophic Scar Formation by Regulating ASIC3-Mediated Fibroblast-Macrophage Crosstalk: A Mechanistic Study. | Phytother Res | 2026 | https://conductscience.org/library/papers/42260901 | PubMed |
| 42253930 | Preclinical Efficacy and Safety Study of a Novel Dermal Fibroblast Modulating Drug, SLI-F06, in Cutaneous Wound Healing. | MedComm (2020) | 2026 | https://conductscience.org/library/papers/42253930 | PubMed |
| 42108543 | Clinical Efficacy of Local Injection of Compound Betamethasone Versus Triamcinolone Acetonide in the Treatment of Hypertrophic Scars: A Retrospective Analysis of 126 Patients. | J Cosmet Dermatol | 2026 | https://conductscience.org/library/papers/42108543 | PubMed |
| 41810075 | Scar Inhibition in Wound Healing: Mechanisms, Design, and Recent Advances. | Exploration (Beijing) | 2026 | https://conductscience.org/library/papers/41810075 | PubMed |
| 41754891 | Research Advances in Therapeutic Strategies and Drug Delivery Systems for Pathological Scars. | Pharmaceutics | 2026 | https://conductscience.org/library/papers/41754891 | PubMed |
| 41707648 | Chemomechanical remodeling of glucocorticoid-sensitive fibroblasts for multimodal synergistic therapy of skin fibrosis. | Cell Rep Med | 2026 | https://conductscience.org/library/papers/41707648 | PubMed |
| 41675148 | Application of IFN-γ-Licensed urine-derived stem cells in SIS hydrogel promotes scar-free wound healing by immunomodulation and microenvironment remodeling. | Bioact Mater | 2026 | https://conductscience.org/library/papers/41675148 | PubMed |
| 41596464 | Transient Receptor Potential (TRP) Channels as Fundamental Regulators of Fibrosis and Pruritus-A New Therapeutic Target for Pathological Scar Management. | Int J Mol Sci | 2026 | https://conductscience.org/library/papers/41596464 | PubMed |
| 41216187 | Single cell deciphering of pruritic keloids: the interaction between fibroblasts and Schwann cells through the Midkine signaling. | Burns Trauma | 2025 | https://conductscience.org/library/papers/41216187 | PubMed |
| 41193897 | Therapeutic Effect of Topical Triamcinolone Acetonide Combined With 10600-nm Ablative Fractional Carbon Dioxide Laser or 1565-nm Non-Ablative Fractional Laser on Hypertrophic Scars in the Rabbit Ear Model. | Aesthetic Plast Surg | 2026 | https://conductscience.org/library/papers/41193897 | PubMed |
| 40918477 | Effects of combined treatment with Curcuma longa extract, curcumin, or bisdemethoxycurcumin and UVA on imiquimod-induced psoriasis-like lesions in BALB/c mice. | Food Sci Biotechnol | 2025 | https://conductscience.org/library/papers/40918477 | PubMed |
| 40852404 | Clinical guidance paper VVOG-CRGOLFB prevention and management of obstetrical perineal trauma. | Eur J Obstet Gynecol Reprod Biol X | 2025 | https://conductscience.org/library/papers/40852404 | PubMed |
| 40703263 | Photobiomodulation therapy in keloid management: a comprehensive review. | Front Med (Lausanne) | 2025 | https://conductscience.org/library/papers/40703263 | PubMed |
Genes9
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| A2M | 2 | PubTator's text mining | https://conductscience.org/library/genes/2 | NCBI Gene |
| ANXA1 | 301 | PubTator's text mining | https://conductscience.org/library/genes/301 | NCBI Gene |
| JUNB | 3726 | PubTator's text mining | https://conductscience.org/library/genes/3726 | NCBI Gene |
| NR3C1 | 2908 | PubTator's text mining | https://conductscience.org/library/genes/2908 | NCBI Gene |
| PLA2G1B | 5319 | PubTator's text mining | https://conductscience.org/library/genes/5319 | NCBI Gene |
| SERPINA1 | 5265 | PubTator's text mining | https://conductscience.org/library/genes/5265 | NCBI Gene |
| STAT3 | 6774 | PubTator's text mining | https://conductscience.org/library/genes/6774 | NCBI Gene |
| TGFB1 | 7040 | PubTator's text mining | https://conductscience.org/library/genes/7040 | NCBI Gene |
| VEGFA | 7422 | PubTator's text mining | https://conductscience.org/library/genes/7422 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/36950503
GET https://conductscience.org/api/papers/v1/36950503/references?page=2